OMNIACTIVE OFFICIAL UNDERWRITER OF SUPPLYSIDE WEST 2017 BLUE LIGHT PANEL DISCUSSION

OmniActive official underwriter of SupplySide West 2017 blue light panel discussion

Morristown, N.J., August 9, 2017 – OmniActive is the official underwriter of the highly anticipated panel discussion Eye Health: Exploring the Blue Light Opportunity during this year’s SupplySide West which runs from September 25-29, 2017 in Las Vegas, NV (US). The session will take place on Thursday, September 28 from 2-4:00 p.m.

While eye health has traditionally been connected to aging, concerns about younger adults are increasing due to the effects of blue light on visual function. This session will give an overview of high energy blue light filtering macular carotenoids lutein ad zeaxanthin isomers which protect the eye from oxidative damage. Attendees will also gain insight around the latest challenges of blue light, its effects on younger adults and the types of nutritional interventions that could help protect vision for a lifetime. The panel will feature discussion from Maryellen Moryneaux, President, Natural Marketing Institute and Julie Poteet, O.D., VP, Ocular Nutrition Society as well as James Stringham, Ph.D., Univ. of Georgia.

As lead researcher of the recent B.L.U.E. (an acronym for Blue Light User Exposure) study, Dr. Stringham will provide an overview of this groundbreaking research which was the subject of a recent paper, “Effects of macular carotenoid supplementation on visual performance, sleep quality, and adverse physical symptoms in those with high screen time exposure,” published in Foods 2017 (Stringham, et al.). This is the first study to examine the impact of supplementation of all three macular carotenoids—lutein, RR- and RS (meso)-zeaxanthin—to protect visual health and performance, improve sleep quality and reduce eye strain and fatigue during prolonged exposure to blue light emitting digital screens.

“The B.L.U.E. study is the first of its kind to demonstrate the importance of macular carotenoids supplementation from Lutemax 2020 on ocular health and performance, sleep quality and eye strain and fatigue during long duration exposure to digital devices. Because of this, it seemed only natural to become the official underwriter of the Eye Health: Exploring the Blue Light Opportunity panel discussion,” said Lynda Doyle, Sr. VP, Global Marketing, OmniActive Health Technologies. “The interest in macular carotenoids continues to grow. The recent publication of our B.L.U.E. study is garnering vast attention and is helping broaden the eye health category to include support against the effects of prolonged digital device use, creating tremendous opportunity.”

OmniActive will also be exhibiting at booth #V147, providing exclusive presentations on Lutemax 2020 Lutein with Enhanced Levels of Zeaxanthin Isomers, Lutemax Free Lutein and Lutein Esters, OmniXan RR-Zeaxanthin, Capsimax Capsicum Extract, CurcuWIN Curcumin with Enhanced Absorption, OmniLean Salacia Extract and Gingever High Potency Ginger.

To schedule a meeting or to discuss our latest science and brands, please contact Sara Zoet at s.zoet@omniactives.com

 

About the B.L.U.E. study

The B.L.U.E. study was a 6-month randomized, double-blind, placebo-controlled supplementation trial with 48 healthy, young adults with screen time exposure of at least 6 hours daily. Subjects were evaluated at baseline, 3-months and 6-months for MPOD (Macular Pigment Optical Density) and markers of visual performance including contrast sensitivity, photostress recovery and disability glare. Sleep quality, which is affected by blue light exposure, and physical indicators of excessive screen use were also measured. The results show that supplementing with all three macular carotenoids—lutein, RR- and RS (meso)-zeaxanthin—Lutemax 2020 significantly improved macular pigment optical density, visual performance and indicators of excessive screen use, including eye strain and fatigue and headache frequency. Sleep quality also improved significantly.

About Lutemax 2020

Award-winning, globally-recognized Lutemax 2020 is a naturally-derived marigold extract providing all three macular carotenoids (lutein and enhanced levels of both zeaxanthin isomers—RR-and RS [meso]-zeaxanthin) at the same 5:1 ratio as found in nature. FDA-GRAS notified Lutemax 2020 is manufactured under a fully vertically integrated source.

About OmniActive Health Technologies, Inc.

OmniActive Health Technologies (www.omniactives.com) offers a range of quality ingredients, which are innovative and scientifically validated for dietary supplementation, nutritional fortification, functional food/beverage, coloring, flavor enhancement and personal care applications. The company addresses complex challenges for customers in the dietary supplement, food and beverage space using technology-driven, sustainable solutions with application support within a global regulatory framework. Whether looking for a new ingredient to add to a finished product, or an ingredient solution to enhance an existing ingredient, you will find unmatched innovation at OmniActive.

Core products include carotenoids, plant extracts and specialty functional ingredients. OmniActive leverages international R&D strengths to deploy an array of state-of-the-art manufacturing technologies in extraction, purification, isolation and delivery of nutritional actives. The company’s manufacturing operations are located at multiple sites in India and are cGMP and HACCP system compliant.

go back to PRESS RELEASES